The Role of Cathelicidin LL-37 in Cancer Development.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The Role of Cathelicidin LL-37 in Cancer Development.
- Published In:
- Archivum immunologiae et therapiae experimentalis, 64(1), 33-46 (2016)
- Authors:
- Piktel, Ewelina(4), Niemirowicz, Katarzyna, Wnorowska, Urszula(3), Wątek, Marzena, Wollny, Tomasz, Głuszek, Katarzyna, Góźdź, Stanisław, Levental, Ilya, Bucki, Robert
- Database ID:
- RPEP-03089
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03089APA
Piktel, Ewelina; Niemirowicz, Katarzyna; Wnorowska, Urszula; Wątek, Marzena; Wollny, Tomasz; Głuszek, Katarzyna; Góźdź, Stanisław; Levental, Ilya; Bucki, Robert. (2016). The Role of Cathelicidin LL-37 in Cancer Development.. Archivum immunologiae et therapiae experimentalis, 64(1), 33-46. https://doi.org/10.1007/s00005-015-0359-5
MLA
Piktel, Ewelina, et al. "The Role of Cathelicidin LL-37 in Cancer Development.." Archivum immunologiae et therapiae experimentalis, 2016. https://doi.org/10.1007/s00005-015-0359-5
RethinkPeptides
RethinkPeptides Research Database. "The Role of Cathelicidin LL-37 in Cancer Development." RPEP-03089. Retrieved from https://rethinkpeptides.com/research/piktel-2016-the-role-of-cathelicidin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.